Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - REVENUE
Revenue ALNY - Alnylam Pharmaceuticals, Inc.
2.25 B
LAST VALUE
47.21%
2 YEAR CAGR
59.21%
5 YEAR CAGR
46.15%
10 YEAR CAGR